LRMR LARIMAR THERAPEUTICS INC

Ownership history in EntryPoint Capital, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in LARIMAR THERAPEUTICS INC (LRMR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.09% (2024 Q1)
Avg. % of fund
0.08%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 53,321 -960 -1.8% 0.08% $203K $3.81
2024 Q4 ADDED 54,281 +36,045 +197.7% 0.09% $210K $3.87
2024 Q3 ADDED 18,236 +4,309 +30.9% 0.07% $119K $6.55
2024 Q1 INITIATED 13,927 0.09% $106K
% of Fund (quarterly)    LRMR price (monthly, adj. close)
← Back to EntryPoint Capital, LLC Holdings